Get started
Author

Maria Pilar Gallego-Hernanz

Observed names: M.-P. Gallego-Hernanz, Maria P. Gallego‐Hernanz, Maria-Pilar Gallego-Hernanz
OpenAlex ID: A5110691271
Ulceroglandular Infection and Bacteremia Caused by Francisella salimarina in Immunocompromised Patient, France
2022 · Aurélie Hennebique, Yvan Caspar, et al. · Emerging infectious diseases · 12
PDF
Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study
2020 · Laetitia Largeaud, Pascale Cornillet-Lefebvre, et al. · Leukemia · 10
PDF
Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation
2020 · Arnon Nagler, Myriam Labopin, et al. · American Journal of Hematology · 8
Asciminib for relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia
2025 · Mathilde Chanut, Aurélie Cabannes-Hamy, et al. · Blood Advances · 7
PDF
Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia
2024 · Nicholas J. Short, Agnieszka Wierzbowska, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 6
PDF
Prognostic impact of FLT3 -ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy
2026 · Nicolas Duployez, Romane Joudinaud, et al. · Blood · 4
Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02)
2025 · Sarah Bertoli, Emilie Bérard, et al. · Haematologica · 1
PDF
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study
2024 · Ludovic Gabellier, Pierre Peterlin, et al. · Annals of Hematology
PDF
Works count: 8
Citation count: 48
H-index: 5
I10-index: 2
Year
Topic
Type